Summary of Key Points Core Viewpoint - The Hong Kong stock market experienced significant net inflows from northbound capital, with a total net buy of 717 million HKD on June 9, 2023, indicating strong investor interest in certain stocks, particularly in the innovative pharmaceutical sector and local businesses like Meituan [1][2]. Group 1: Northbound Capital Inflows and Outflows - Northbound capital had a net buy of 12.47 billion HKD through the Shenzhen Stock Connect and a net sell of 5.3 billion HKD through the Shanghai Stock Connect [1]. - The stocks with the highest net inflows included Xinda Bio (01801), Meituan-W (03690), and Li Auto-W (02015) [1]. - The stocks with the highest net outflows were Tencent (00700), Xiaomi Group-W (01810), and Alibaba-W (09988) [1]. Group 2: Active Stocks and Their Performance - Meituan-W (03690) saw a net buy of 10.46 billion HKD, supported by strong fundamentals and a solid merchant base [5]. - Xinda Bio (01801) received a net buy of 7.73 billion HKD, benefiting from favorable developments in the pharmaceutical sector [4]. - Alibaba-W (09988) and Tencent (00700) faced significant net sells of 9.39 billion HKD and 21.41 billion HKD, respectively, due to concerns over capital expenditures and cloud revenue growth [6]. Group 3: Sector Trends and Insights - The innovative pharmaceutical sector is gaining traction, with Xinda Bio, Shiyao Group, and Sanofi Pharmaceutical receiving substantial net buys, reflecting a positive outlook for domestic innovative drugs [4]. - The automotive sector showed mixed results, with Li Auto-W (02015) gaining 4.52 billion HKD while Xiaomi Group-W (01810) faced a net sell of 14.52 billion HKD, indicating ongoing challenges in the industry [5]. - The banking sector, represented by China Bank (03988), attracted a net buy of 326.7 million HKD, driven by stable fundamentals and dividend attractiveness [6].
北水动向|北水成交净买入7.17亿 内资继续加仓创新药概念股 全天抢筹信达生物(01801)超11亿港元